Company Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.

The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics.

The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

InterCure Ltd.

Country	Israel
Founded	1994
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	320
CEO	Alexander Rabinovich

Contact Details

Address: 85 Medinat ha-Yehudim Street Herzliya, 4676670 Israel
Phone	972 7 746 05012
Website	intercure.co

Stock Details

Ticker Symbol	INCR
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	ILS
IPO Price	$0.00
CIK Code	0001857030
CUSIP Number	M549GJ111
ISIN Number	IL0011063760
SIC Code	2834

Key Executives

Name	Position
Alexander Rabinovich	Chief Executive Officer and Chairman
Amos Cohen	Chief Financial Officer
Einat Zehavi	Vice President of Sales
Itai Kabiljo	General Counsel

Latest SEC Filings

Date	Type	Title
Mar 3, 2026	6-K	Report of foreign issuer
Feb 19, 2026	6-K	Report of foreign issuer
Dec 30, 2025	6-K	Report of foreign issuer
Dec 18, 2025	6-K	Report of foreign issuer
Dec 9, 2025	SCHEDULE 13D	Filing
Nov 25, 2025	6-K	Report of foreign issuer
Nov 3, 2025	6-K	Report of foreign issuer
Oct 8, 2025	6-K	Report of foreign issuer
Sep 19, 2025	6-K	Report of foreign issuer
Aug 29, 2025	UPLOAD	Filing

View All SEC Filings